Skip to main content
Contact Us
Subscribe
E-Edition
88°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Masimo Corporation - Common Stock
(NQ:
MASI
)
168.22
+0.01 (+0.01%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 30, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Masimo Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 06, 2022
Gainers
Via
Benzinga
Masimo's Return On Capital Employed Overview
December 06, 2022
Via
Benzinga
Expert Ratings for Masimo
December 05, 2022
Via
Benzinga
7 Analysts Have This to Say About Masimo
December 05, 2022
Via
Benzinga
Over $17 Million Bet On Element Solutions? Check Out These 3 Stocks Insiders Are Buying
November 16, 2022
Although US stocks closed higher on Tuesday, there were a few notable insider trades.
Via
Benzinga
6 Analysts Have This to Say About Masimo
November 09, 2022
Within the last quarter, Masimo (NASDAQ:MASI) has observed the following analyst ratings:
Via
Benzinga
Masimo's Earnings Outlook
November 07, 2022
Masimo (NASDAQ:MASI) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Masimo will report an...
Via
Benzinga
2 Under-the-Radar Medtech Stocks to Buy Now
November 05, 2022
Don't count out these discounted medical technology stocks.
Via
The Motley Fool
Where Masimo Stands With Analysts
October 12, 2022
Masimo (NASDAQ:MASI) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Where Masimo Stands With Analysts
September 14, 2022
Within the last quarter, Masimo (NASDAQ:MASI) has observed the following analyst ratings:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
October 12, 2022
Upgrades
Via
Benzinga
Masimo Clocks 85% Jump In Quarterly Sales, Provides Q3 Guidance Below Expectations
August 10, 2022
Via
Benzinga
7 Analysts Have This to Say About Masimo
May 04, 2022
Masimo (NASDAQ:MASI) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Masimo Posts Better Than Expected Q1 Earnings Despite 'Unexpected' Supply Chain Issues
May 04, 2022
Via
Benzinga
Accenture Price Target Cut By This Analyst, Plus Deutsche Bank Predicts $483 For FactSet Research
September 23, 2022
Credit Suisse cut FedEx Corporation (NYSE: FDX) price target from $246 to $236. FedEx shares fell 1.9% to $151.56 in pre-market trading.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2022
September 15, 2022
Upgrades
Via
Benzinga
Supply Chain Challenges To Hit Masimo's Q1 FY22 Sales
March 31, 2022
Via
Benzinga
Why Jim Cramer Recommends Buying Norwegian Cruise Line
March 03, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Norwegian Cruise Line Holdings Ltd. (NYSE...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
September 14, 2022
Upgrades For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral to Buy. The current stock performance of Iris Energy shows a 52-week-high of $17.97 and a 52-week-low...
Via
Benzinga
Citigroup Slashes Price Target On This Stock By 83%; Also Check Out Some Other Big PT Changes
August 10, 2022
RBC Capital cut the price target for Nuvei Corporation (NASDAQ: NVEI) from $80 to $60. Nuvei shares fell 21.5% to close at $33.03 on Tuesday.
Via
Benzinga
7 Best High-Growth Stocks for Young Investors
July 19, 2022
The best high-growth stocks for young investors are poised to outperform once again once the markets turn positive.
Via
InvestorPlace
Masimo's Return on Invested Capital Insights
May 13, 2022
According to Benzinga Pro, during Q1, Masimo (NASDAQ:MASI) earned $46.59 million, a 31.74% increase from the preceding quarter. Masimo's sales decreased to $304.24 million, a 7.12% change since Q4.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
May 03, 2022
Gainers
Via
Benzinga
Masimo's Earnings Outlook
May 02, 2022
Masimo (NASDAQ:MASI) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Masimo will report an...
Via
Benzinga
10 Biggest Price Target Changes For Thursday
March 31, 2022
Goldman Sachs raised the price target on Consolidated Edison, Inc. (NYSE: ED) from $65 to $83. Consolidated Edison shares rose 0.5% to trade at $95.24 on Thursday.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022
April 06, 2022
Upgrades
Via
Benzinga
The Daily Biotech Pulse: Amylyx Announces Negative Adcom Vote, Clovis Jumps On Ovarian Cancer Data, Masimo Warns Of Q1 Shortfall
March 31, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Analyst Ratings For Masimo
March 17, 2022
Analysts have provided the following ratings for Masimo (NASDAQ:MASI) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings...
Via
Benzinga
Masimo's SedLine Brain Function Monitor Sensor Scores FDA Approval For Pediatric Use
February 28, 2022
The FDA has FDA cleared Masimo Corp's (NASDAQ: MASI) SedLine brain function monitoring for pediatric patients (1-17 years of age) and the SedLine Pediatric EEG...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 18, 2022
February 18, 2022
Upgrades Roth Capital upgraded the previous rating for Denbury Inc (NYSE:DEN) from Neutral to Buy. For the third quarter, Denbury had an EPS of $0.74, compared to year-ago...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.